Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Covenant Children's Hospital
mi
from
Lubbock, TX
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Covenant Children's Hospital
mi
from
Lubbock, TX
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Primary Children's Hospital
mi
from
Salt Lake City, UT
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
University of Vermont College of Medicine
mi
from
Burlington, VT
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
University of Vermont College of Medicine
mi
from
Burlington, VT
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
University of Virginia
mi
from
Charlottesville, VA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Carilion Clinic Children's Hospital
mi
from
Roanoke, VA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Carilion Clinic Children's Hospital
mi
from
Roanoke, VA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
West Virginia University Charleston
mi
from
Charleston, WV
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
West Virginia University Charleston
mi
from
Charleston, WV
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Marshfield Clinic
mi
from
Marshfield, WI
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated:  1/12/2017
Children's Hospital at Westmead
mi
from
Westmead,
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Status: Enrolling
Updated: 1/12/2017
Children's Hospital at Westmead
mi
from
Westmead,
Click here to add this to my saved trials
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Probiotic Enteric Regimen For Easing Complications of Transplant : A Pilot Study (PERFECT Trial)
Status: Enrolling
Updated:  2/2/2017
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Probiotic Enteric Regimen For Easing Complications of Transplant : A Pilot Study (PERFECT Trial)
Status: Enrolling
Updated: 2/2/2017
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated:  2/6/2017
City of Hope Medical Center
mi
from
Duarte, CA
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated: 2/6/2017
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated:  2/6/2017
University of Chicago
mi
from
Chicago, IL
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated: 2/6/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated:  2/6/2017
The Ohio State University Medical Center, Dept. Neurological Surgery
mi
from
Columbus, OH
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated: 2/6/2017
The Ohio State University Medical Center, Dept. Neurological Surgery
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated:  2/6/2017
Methodist Hospital - The Neurological Institute
mi
from
Houston, TX
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
Status: Enrolling
Updated: 2/6/2017
Methodist Hospital - The Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Riley Hospital for Children at IU Health
mi
from
Indianapolis, IN
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Riley Hospital for Children at IU Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Children's Hospital at Montefiore
mi
from
Bronx, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Maimonides Medical Center
mi
from
Brooklyn, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
NYU Langone Medical Center
mi
from
New York, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Mount Sinai Hospital
mi
from
New York, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
A Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Adjuvant Everolimus Following the Resection of Metastatic Pancreatic Neuroendocrine Tumors to the Liver
Status: Enrolling
Updated:  2/7/2017
Eastern Cooperative Oncology Group
mi
from
Boston, MA
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
A Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Adjuvant Everolimus Following the Resection of Metastatic Pancreatic Neuroendocrine Tumors to the Liver
Status: Enrolling
Updated: 2/7/2017
Eastern Cooperative Oncology Group
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated:  2/15/2017
Clinical Research Facility
mi
from
Indianapolis, IN
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated: 2/15/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated:  2/15/2017
Clinical Research Facility
mi
from
La Jolla, CA
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated: 2/15/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated:  2/15/2017
Clinical Research Facility
mi
from
San Francisco, CA
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated: 2/15/2017
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated:  2/15/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated: 2/15/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated:  2/15/2017
Clinical Research Facility
mi
from
Chicago, IL
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated: 2/15/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated:  2/15/2017
Clinical Research Facility
mi
from
Durham, NC
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated: 2/15/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated:  2/15/2017
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Frankfurt,
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Status: Enrolling
Updated: 2/15/2017
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Frankfurt,
Click here to add this to my saved trials
A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
A Pilot Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
Status: Enrolling
Updated:  2/28/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
A Pilot Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
Status: Enrolling
Updated: 2/28/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated:  2/28/2017
Northwestern University
mi
from
Chicago, IL
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated: 2/28/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated:  2/28/2017
University of Iowa Health Care
mi
from
Iowa City, IA
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated: 2/28/2017
University of Iowa Health Care
mi
from
Iowa City, IA
Click here to add this to my saved trials
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated:  2/28/2017
LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Deptof LSU Health Sciences (2)
mi
from
New Orleans, LA
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated: 2/28/2017
LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Deptof LSU Health Sciences (2)
mi
from
New Orleans, LA
Click here to add this to my saved trials
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated:  2/28/2017
Weill Medical College of Cornell University
mi
from
New York, NY
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated: 2/28/2017
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated:  2/28/2017
Oregon Health and Sciences University
mi
from
Portland, OR
EPO906 in Carcinoid and Other Neuroendocrine Tumors
EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
Status: Enrolling
Updated: 2/28/2017
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated:  3/15/2017
Barrow Neurology Clinics
mi
from
Phoenix, AZ
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated: 3/15/2017
Barrow Neurology Clinics
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated:  3/15/2017
Baylor
mi
from
Dallas, TX
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated: 3/15/2017
Baylor
mi
from
Dallas, TX
Click here to add this to my saved trials
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated:  3/15/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated: 3/15/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated:  3/15/2017
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Status: Enrolling
Updated: 3/15/2017
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials